Odefsey

Indicated For

HIV

About This Medication

# **Gilead Advancing Access Program** Patient Guide: How to Get **Odefsey** (emtricitabine/rilpivirine/tenofovir alafenamide) at Low or No Cost Odefsey is a prescription medication used to treat HIV-1 infection in adults and children who weigh at least 77 lbs (35 kg). It combines three antiretroviral drugs—**emtricitabine**, **rilpivirine**, and **tenofovir alafenamide**—in one tablet taken once daily. This fixed-dose combination helps suppress the virus, reduce viral load, and improve immune function when used as part of a complete HIV treatment regimen. Always take it as prescribed by your healthcare provider, with food to improve absorption, and do not skip doses to avoid developing drug resistance. The **Gilead Advancing Access Program**, offered by **Gilead Sciences**, provides **Odefsey at no cost** to eligible uninsured patients through its Patient Assistance Program (PAP) or Medication Assistance Program (MAP). This guide explains eligibility, application steps, and more to help you access your medication easily. ## Who Qualifies for the Program? To qualify, you must: - Be a legal resident of the **United States, Puerto Rico, or U.S. Territories**. - Have a valid prescription for **Odefsey** from a licensed U.S. healthcare provider. - Meet **income eligibility** based on Federal Poverty Level (FPL). - Be **uninsured** or underinsured (Medicare Part D patients are **not eligible**). - Not be eligible for government programs like Medicaid that fully cover the medication. Proof of residency and income may be required. The program verifies your information to ensure assistance goes to those who need it most. ## Income Eligibility Breakdown Eligibility is based on your **household income** compared to the **Federal Poverty Level (FPL)**. Exact percentages (e.g., up to 400% or 500% FPL) are not specified in program materials but are typically standard for Gilead programs—call **(800) 226-2056** for your specific situation. Use the table below as a general guide (2026 FPL estimates; confirm current levels at ASPE.hhs.gov). | Household Size | Annual Income Threshold (approx. 400% FPL) | Example Monthly Income | |---------------|--------------------------------------------|-------------------------| | 1 person | $60,240 | $5,020 | | 2 people | $81,760 | $6,813 | | 3 people | $103,280 | $8,607 | | 4 people | $124,800 | $10,400 | *Add ~$21,520 per additional person.* Income includes wages, Social Security, etc. Provide proof like pay stubs, tax returns, or W-2s. If your income changes, reapply. ## Insurance Requirements - **Uninsured patients** qualify for free medication via PAP/MAP. - **Medicare Part D patients are not eligible**—explore other Gilead options like co-pay assistance if commercially insured. - The program checks insurance status; disclose all coverage accurately to avoid termination. - If you gain insurance later, notify Advancing Access immediately. ## Step-by-Step Application Process 1. **Get Your Prescription**: Ask your doctor to complete the prescriber section of the enrollment form. 2. **Download or Request Form**: Get the **Advancing Access Program Enrollment Form** (English/Spanish) from GileadAdvancingAccess.com. 3. **Fill Out Patient Section**: Provide name, address, phone, email, DOB, last 4 SSN digits, household income, and sign consents for info sharing. 4. **Gather Documents**: - **Proof of income** (e.g., last two pay stubs, W-2, tax return). - **Proof of residency** (e.g., utility bill, ID). - **Completed enrollment form** signed by you and your doctor. 5. **Submit** (multiple methods): - **Fax**: 1-800-216-6857 (check form for exact number). - **Phone**: Call **(800) 226-2056** (Mon-Fri, 9am-8pm ET) for help or verbal enrollment. - **Online**: Via HCP iAssist portal or patient portal if available. 6. **Wait for Review**: Processed in **2 business days**. 7. **Follow Up**: Expect a call from a program specialist to confirm details or request more info. Your medication ships directly to your home if approved. ## Timeline and Delivery - **Processing**: **2 business days** after complete submission. - **Approval Notification**: Via phone/email; specialist guides next steps. - **Delivery**: Shipped free to your address via ARx Patient Solutions Pharmacy. - **Refills**: **Reauthorization required** annually or upon income/insurance changes. Your doctor resubmits prescription; program contacts you. ## Alternatives if Denied - **Appeal**: Call **(800) 226-2056** to discuss reasons (e.g., income too high, insured status) and resubmit updated docs. - **Co-pay Program**: If commercially insured, apply for savings card. - **Other Assistance**: State AIDS Drug Assistance Programs (ADAP), Ryan White programs, or patient access networks like PAN Foundation. - **Generic Options**: No biosimilars for Odefsey; discuss alternatives like Delstrigo with your doctor. - **Reapply**: If circumstances change (e.g., job loss). ## Important Disclaimer This guide is for informational purposes only and based on publicly available program details as of 2026. Eligibility, terms, and availability can change—Gilead may modify or end the program without notice. Assistance terminates if false info is provided or medication is no longer prescribed. Consult your healthcare provider for medical advice; do not change treatment without guidance. Verify details by calling **(800) 226-2056** or visiting GileadAdvancingAccess.com. Gilead does not guarantee approval.

Program information last verified: March 29, 2026